Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to JP58216509ApriorityCriticalpatent/JPS60109582A/ja
Publication of JPS60109582ApublicationCriticalpatent/JPS60109582A/ja
Publication of JPS6337084B2publicationCriticalpatent/JPS6337084B2/ja
Novel 3-aryl-2-hydroxypropionic acid derivative for use in conditions associated with insulin resistance and pharmaceutical composition containing same
Synthesis, characterization, and in vitro evaluation and in silico molecular docking of thiourea derivatives incorporating 4-(trifluoromethyl) phenyl moiety
Synthesis, crystal structures and DFT studies of 1-[2-(5-methyl-2-benzoxazolinone-3-yl) acetyl]-3-phenyl-5-(3, 4-dimethoxyphenyl)-4, 5-dihydro-1H-pyrazole and 1-[2-(5-chloro-2-benzoxazolinone-3-yl) acetyl]-3-phenyl-5-(4-methoxyphenyl)-4, 5-dihydro-1H-pyrazole